Quarterly Dividends, Invitations to Conference Calls, Completion of Acquisitions, and Certifications for Healthcare Products -

     Quarterly Dividends, Invitations to Conference Calls, Completion of
Acquisitions, and Certifications for Healthcare Products - Research Report on
              Covidien, Bard, Mindray, CareFusion, and DENTSPLY

Editor Note: For more information about this release, please scroll to bottom

PR Newswire

NEW YORK, July 23, 2013

NEW YORK, July 23, 2013 /PRNewswire/ --

Today, Investors' Reports announced new research reports highlighting Covidien
plc (NYSE: COV), C.R. Bard, Inc. (NYSE: BCR), Mindray Medical International
Limited (NYSE: MR), CareFusion Corporation (NYSE: CFN), and DENTSPLY
International Inc. (NASDAQ: XRAY). Today's readers may access these reports
free of charge - including full price targets, industry analysis and analyst
ratings - via the links below.

Covidien plc Research Report

On July 17, 2013, Covidien plc (Covidien) announced that the Company's Board
of Directors has declared a quarterly cash dividend of $0.26 per ordinary
share. The dividend is payable on August 15, 2013 to shareholders of record as
of the close of business on July 30, 2013. Covidien previously announced that
it will report its Q3 FY 2013 results on August 1, 2013 before trading begins,
and hold a conference call for investors at 8:30 a.m. ET on the same day. The
Full Research Report on Covidien plc - including full detailed breakdown,
analyst ratings and price targets - is available to download free of charge
at: [http://www.investorsreports.com/report/2013-07-18/COV]

--

C.R. Bard, Inc. Research Report

On July 9, 2013, C.R. Bard, Inc. (Bard) announced that it will host a
conference call on July 23, 2013 at 5:00 p.m. EDT, to discuss the Company's Q2
2013 operating results, as well as to provide financial guidance for Q3 2013.
Bard informed that the earnings press release will be issued on the same day,
after the market closes. In Q1 2013, Bard reported a 1% YoY increase in net
sales, amounting to $740.3 million. Q1 2013 net income was $90.7 million and
diluted EPS was $1.08, a decrease of 35% YoY and 33% YoY, respectively. The
Full Research Report on C.R. Bard, Inc. - including full detailed breakdown,
analyst ratings and price targets - is available to download free of charge
at: [http://www.investorsreports.com/report/2013-07-18/BCR]

--

Mindray Medical International Limited Research Report

On July 17, 2013, Mindray Medical International Limited (Mindray) announced
the completion of its acquisition of ZONARE Medical Systems, Inc. (ZONARE),
pursuant to the terms of the previously announced definitive agreement entered
into on June 12, 2013. Under the agreement, Mindray acquired ZONARE for a
total purchase price of $101.7 million in cash, as adjusted for working
capital at the closing date. Mindray expects that the combined business will
benefit from ZONARE's strong innovative R&D capability and direct sales and
service network in the high-end ultrasound market together with Mindray's
efficient engineering, extensive distribution channels, and broad production
platforms. The Full Research Report on Mindray Medical International Limited -
including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:
[http://www.investorsreports.com/report/2013-07-18/MR]

--

CareFusion Corporation Research Report

On July 16, 2013, CareFusion Corporation (CareFusion) announced that it was
one of the first groups of health IT products providers that has received
certification under a new healthcare certification program launched by IHE USA
and ICSA Labs. The Company informed that under the certification program, the
products met rigorous testing requirements for security and interoperability.
CareFusion also stated that the certification builds on specifications of the
Federal Office of the National Coordinator for Health IT, giving purchasers of
health IT products independent third-party verification that products are
suitable for health data exchange and function as intended. The certification
program will expand by utilizing virtual testing events in fall of 2013,
leading up to the 2014 IHE North American Connectathon to be held from January
27 to January 31, 2014 in Chicago. The Full Research Report on CareFusion
Corporation - including full detailed breakdown, analyst ratings and price
targets - is available to download free of charge at:
[http://www.investorsreports.com/report/2013-07-19/CFN]

--

DENTSPLY International Inc. Research Report

On July 15, 2013, DENTSPLY International Inc. (DENTSPLY) announced that it
will release its Q2 2013 earnings results on August 1, 2013 at 7:00 a.m. ET.
Following the press release, the Company will host a conference call with a
live webcast to discuss the financial results. In its Q1 2013 earnings results
release, Bret Wise, Chairman and CEO of DENTSPLY commented on the Company's
full-year 2013 outlook, "Looking forward, we believe that we have
opportunities to accelerate growth in both sales and earnings as the year
progresses. Given the current market environment and currency exchange rates,
we are revising our expectations for adjusted earnings per share for 2013 to a
range of $2.33 to $2.43." The Full Research Report on DENTSPLY International
Inc. - including full detailed breakdown, analyst ratings and price targets -
is available to download free of charge at:
[http://www.investorsreports.com/report/2013-07-19/XRAY]

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by a CFA. However, we are only human and are prone to
    make mistakes. If you notice any errors or omissions, please notify us
    below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider has, through Chartered Financial
Analysts, only reviewed the information provided by Equity News Network in
this article or report according to the Procedures outlined by Equity News
Network. Equity News Network is not entitled to veto or interfere in the
application of such procedures by the outsourced provider to the articles,
documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

SOURCE Investors' Reports

Contact: Kristi Saunders - CONTACT PHONE: +1-315-982-6420 (North America)
 
Press spacebar to pause and continue. Press esc to stop.